TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 17626210

Group type: EXPERIMENTAL
Intervention: Cowhage
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Histamine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Topical Capsaicin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Antihistamine
Number of subjects: 0
Study: 15174218

Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen therapy (HBO)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Control (normal air)
Number of subjects: 71
Study: 12226033

Group type: EXPERIMENTAL
Intervention: Moxifloxacin (400 mg once daily)
Number of subjects: 556

Group type: EXPERIMENTAL
Intervention: Standard oral treatment (amoxicillin, 1 g tid, or clarithromycin, 500 mg bid)
Number of subjects: 556

Group type: EXPERIMENTAL
Intervention: Combination of moxifloxacin and standard oral treatment
Number of subjects: 556

Group type: EXPERIMENTAL
Intervention: CAP-Sym questionnaire
Number of subjects: 556
Study: 9839848

Group type: EXPERIMENTAL
Intervention: Running program (10 weeks)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38

Group type: COMPARATOR
Intervention: Clomipramine
Number of subjects: 38

Group type: COMPARATOR
Intervention: Healthy controls (untrained)
Number of subjects: 38
Study: 8073385

Group type: EXPERIMENTAL
Intervention: High-dose oral supplementation of alpha-tocopherol (825 mg daily), ascorbic acid (450 mg daily), and beta-carotene (45 mg daily) for three weeks prior to chemo- and radiotherapy.
Number of subjects: 22

Group type: COMPARATOR
Intervention: No oral supplementation of antioxidants prior to chemo- and radiotherapy (control group).
Number of subjects: 22
Study: 2643996

Group type: EXPERIMENTAL
Intervention: Bromocriptine (2.5 mg/day)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 30972684

Group type: EXPERIMENTAL
Intervention: Sediment samples collected during summer and winter seasons; metals analyzed include Cd, Pb, Ni, Cu, Zn, Cr, As, Mn.
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Macrophytes sampled during summer and winter seasons; metals analyzed include Mn, As, Ni, Zn, Cr, Cd, Pb.
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Contamination degree (Cd) measured in lakes.
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Pollution load index calculated for lakes.
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: PCA applied on sediment and macrophytes.
Number of subjects: 15
Study: 28260235

Group type: EXPERIMENTAL
Intervention: Exenatide once-weekly (Bydureon™)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 24343457

Group type: EXPERIMENTAL
Intervention: Balneotherapy in addition to physiotherapy
Number of subjects: 46

Group type: COMPARATOR
Intervention: Physiotherapy (exercise and transcutaneous electrical nerve stimulation)
Number of subjects: 46
Study: 22111809

Group type: EXPERIMENTAL
Intervention: Bilateral distal implants with ball abutments (retentive anchors)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Conventional mandibular partial dentures
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Bilateral distal implants with healing caps
Number of subjects: 48
Study: 21883197

Group type: EXPERIMENTAL
Intervention: onabotulinumtoxinA (155-195 U)
Number of subjects: 1384

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 1384
Study: 19401477

Group type: EXPERIMENTAL
Intervention: Community pharmacist-provided extended diabetes care service
Number of subjects: 78

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 78
Study: 16676893

Group type: EXPERIMENTAL
Intervention: Storytelling
Number of subjects: 42

Group type: COMPARATOR
Intervention: Psychoeducational information
Number of subjects: 42
Study: 15346695

Group type: EXPERIMENTAL
Intervention: Guideline-based intervention (comprehensive education, prescribed diet, intensive pharmacological therapy)
Number of subjects: 418

Group type: COMPARATOR
Intervention: Control group (normally-discharged patients)
Number of subjects: 418

Group type: EXPERIMENTAL
Intervention: Guideline-based intervention
Number of subjects: 418

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 418

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 418
Study: 11689579

Group type: EXPERIMENTAL
Intervention: Coordinated psychosocial interventions based on patient self-assessments
Number of subjects: 450

Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 450
Study: 8994482

Group type: EXPERIMENTAL
Intervention: SPECT scanning with B pattern as positive
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: SPECT scanning with B or C as positive
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: SPECT scanning with B or C or D as positive
Number of subjects: 120
Study: 8216656

Group type: EXPERIMENTAL
Intervention: Continuity clinic exposure (10 students)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Non-continuity clinic exposure (30 students)
Number of subjects: 40
Study: 3305080

Group type: EXPERIMENTAL
Intervention: Extended mastectomy (EM)
Number of subjects: 243

Group type: COMPARATOR
Intervention: Radical mastectomy (RM)
Number of subjects: 243
Study: 31870950

Group type: EXPERIMENTAL
Intervention: Emricasan 5 mg
Number of subjects: 263

Group type: EXPERIMENTAL
Intervention: Emricasan 25 mg
Number of subjects: 263

Group type: EXPERIMENTAL
Intervention: Emricasan 50 mg
Number of subjects: 263

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 263

Group type: EXPERIMENTAL
Intervention: Emricasan (all doses)
Number of subjects: 263
Study: 29715354

Group type: EXPERIMENTAL
Intervention: Atropine with Propofol
Number of subjects: 173

Group type: COMPARATOR
Intervention: Atropine with Atracurium and Sufentanil
Number of subjects: 173
Study: 28188024

Group type: EXPERIMENTAL
Intervention: Robotic-assisted gait training therapy (RAGT) using Lokomat®Pediatric, 20 sessions
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control Group receiving only daily physiotherapy
Number of subjects: 30
Study: 25156528

Group type: EXPERIMENTAL
Intervention: Enhanced Internet plus phone (proactive telephone counseling)
Number of subjects: 1236

Group type: EXPERIMENTAL
Intervention: Enhanced Internet (online social network)
Number of subjects: 1236

Group type: COMPARATOR
Intervention: Basic Internet (static Internet comparison condition)
Number of subjects: 1236
Study: 23300153

Group type: EXPERIMENTAL
Intervention: Higher cystatin C levels (quartile 4)
Number of subjects: 4709

Group type: COMPARATOR
Intervention: Serum creatinine and creatinine-based estimated glomerular filtration rate (eGFRCr)
Number of subjects: 4709
Study: 21196773

Group type: EXPERIMENTAL
Intervention: Multifaceted semitailored intervention programme (counselling programme, teaching courses, written information, logbooks)
Number of subjects: 330

Group type: COMPARATOR
Intervention: Follow-up only (control group)
Number of subjects: 330
Study: 18056755

Group type: EXPERIMENTAL
Intervention: Adalimumab 40 mg every other week
Number of subjects: 315

Group type: EXPERIMENTAL
Intervention: Adalimumab after 1 year
Number of subjects: 315

Group type: EXPERIMENTAL
Intervention: Adalimumab after 2 years
Number of subjects: 315

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 315
Study: 17156168

Group type: EXPERIMENTAL
Intervention: AUDIT total score (8-15, 16-19, 20-40)
Number of subjects: 1335

Group type: EXPERIMENTAL
Intervention: AUDIT zone with scores of 20 and above
Number of subjects: 1335
Study: 12771973

Group type: EXPERIMENTAL
Intervention: Fish oil (4 g daily)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Corn oil (4 g daily)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Fish oil
Number of subjects: 44

Group type: COMPARATOR
Intervention: Corn oil
Number of subjects: 44
Study: 10685811

Group type: EXPERIMENTAL
Intervention: Occupational lifting of 25 kg in the individual's first job
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Occupational lifting of 50 kg in their main job
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Spending > 2 h each day sitting during their first job
Number of subjects: 114

Group type: COMPARATOR
Intervention: Obesity (highest vs lowest thirds of distribution of body mass index)
Number of subjects: 114
Study: 9474428

Group type: EXPERIMENTAL
Intervention: Sliding screw plate and a parallel cancellous screw (SSP)
Number of subjects: 225

Group type: COMPARATOR
Intervention: Two Olmed screws
Number of subjects: 225
Study: 8174729

Group type: EXPERIMENTAL
Intervention: 3.6 mM pentoxifylline alone
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: 3.0 mM 2‐deoxyadenosine combined with 3.6 mM pentoxifylline
Number of subjects: 121

Group type: COMPARATOR
Intervention: Control sperm preparation
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Treated sperm preparations
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Sperm stimulation
Number of subjects: 121
Study: 3356086

Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study: 30361757

Group type: EXPERIMENTAL
Intervention: Uncemented fixation with titanium fiber mesh coating
Number of subjects: 41

Group type: COMPARATOR
Intervention: Cemented fixation
Number of subjects: 41
Study: 28533194

Group type: EXPERIMENTAL
Intervention: Volatile anesthetic
Number of subjects: 10600

Group type: COMPARATOR
Intervention: Total intravenous anesthesia
Number of subjects: 10600
Study: 25867743

Group type: EXPERIMENTAL
Intervention: Remote limb ischemic conditioning (RLIC)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Sham conditioning
Number of subjects: 18
Study: 23276549

Group type: EXPERIMENTAL
Intervention: Adalimumab
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 21056414

Group type: EXPERIMENTAL
Intervention: Husband/partner present during labor
Number of subjects: 197

Group type: COMPARATOR
Intervention: No husband/partner present during labor
Number of subjects: 197
Study: 17945197

Group type: EXPERIMENTAL
Intervention: Selective serotonin reuptake inhibitor (SSRI) citalopram
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Substance P (SP) antagonist CP-96345
Number of subjects: 51

Group type: COMPARATOR
Intervention: Glucocorticoid antagonist RU486
Number of subjects: 51
Study: 16546279

Group type: EXPERIMENTAL
Intervention: Tomotherapy (TOMO-a)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Tomotherapy (TOMO-b)
Number of subjects: 5

Group type: COMPARATOR
Intervention: IMRT
Number of subjects: 5
Study: 12921879

Group type: EXPERIMENTAL
Intervention: Live Lactobacillus johnsonii La1
Number of subjects: 326

Group type: COMPARATOR
Intervention: Heat-killed Lactobacillus johnsonii La1
Number of subjects: 326

Group type: COMPARATOR
Intervention: Live Lactobacillus paracasei ST11
Number of subjects: 326

Group type: COMPARATOR
Intervention: Heat-killed Lactobacillus paracasei ST11
Number of subjects: 326

Group type: COMPARATOR
Intervention: Vehicle (control group)
Number of subjects: 326
Study: 12796071

Group type: EXPERIMENTAL
Intervention: Moderate-intensity exercise for 16 months
Number of subjects: 131

Group type: COMPARATOR
Intervention: Control group (sedentary)
Number of subjects: 131
Study: 10195530

Group type: EXPERIMENTAL
Intervention: Sameridine 15 mg
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Sameridine 20 mg
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Sameridine 23 mg
Number of subjects: 140

Group type: COMPARATOR
Intervention: Lidocaine 100 mg
Number of subjects: 140
Study: 8897012

Group type: EXPERIMENTAL
Intervention: GLP-1 (50 pmol.kg‐1.h‐1) infusion
Number of subjects: 7

Group type: COMPARATOR
Intervention: 154 mmol/l NaCl (placebo) infusion
Number of subjects: 7
Study: 10146956

Group type: EXPERIMENTAL
Intervention: Oral ofloxacin
Number of subjects: 126

Group type: COMPARATOR
Intervention: Standard parenteral therapy
Number of subjects: 126
Study: 6094455

Group type: EXPERIMENTAL
Intervention: Cefotaxime 1.0 g
Number of subjects: 1500

Group type: COMPARATOR
Intervention: Cefuroxime 1.5 g
Number of subjects: 1500
Study: 3534018

Group type: EXPERIMENTAL
Intervention: Tretinoin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Motretinide
Number of subjects: 0

Group type: COMPARATOR
Intervention: Systemic administration of etretinate
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: A-scan ultrasound and laser Doppler flowmetry
Number of subjects: 0
Study: 30922323

Group type: EXPERIMENTAL
Intervention: Ramucirumab plus paclitaxel (switch maintenance)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Continuation of first-line therapy with oxaliplatin/fluoropyrimidine (control)
Number of subjects: 0
Study: 28488380

Group type: EXPERIMENTAL
Intervention: Capox (oxaliplatin 60 mg/m2 weekly with capecitabine 825 mg/m2 twice daily)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Cap (capecitabine 825 mg/m2 twice daily)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Capox
Number of subjects: 63

Group type: COMPARATOR
Intervention: Cap
Number of subjects: 63
Study: 25332100

Group type: EXPERIMENTAL
Intervention: Metformin (425 mg/d) for 24 months
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study: 23968892

Group type: EXPERIMENTAL
Intervention: CBTpA+SC
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: FIpA+SC
Number of subjects: 30

Group type: COMPARATOR
Intervention: SC alone
Number of subjects: 30
Study: 21503849

Group type: EXPERIMENTAL
Intervention: Manual insertion of mini-implants after pre-drilling with a dental handpiece
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Self-drilling mini-implants inserted without pre-drilling
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Injection of local anesthetic next to the insertion region
Number of subjects: 30

Group type: COMPARATOR
Intervention: Standard injection methods
Number of subjects: 30
Study: 19222849

Group type: EXPERIMENTAL
Intervention: Serum CRP in NAFLD (simple steatosis and steatohepatitis)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Serum PCT in NAFLD (simple steatosis and steatohepatitis)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 100
Study: 17053867

Group type: EXPERIMENTAL
Intervention: Flap repair with fibrin glue
Number of subjects: 58

Group type: COMPARATOR
Intervention: Flap repair alone
Number of subjects: 58
Study: 15815074

Group type: EXPERIMENTAL
Intervention: Diabetic subjects
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Type 2 diabetic subjects with complications
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 0
Study: 11483264

Group type: EXPERIMENTAL
Intervention: DTaP‐IPV/Hib (mix)
Number of subjects: 400
Study: 9256585

Group type: EXPERIMENTAL
Intervention: Parent-assisted social skills training program (12 sessions); stimulant medication prescribed for all children with ADHD.
Number of subjects: 49

Group type: COMPARATOR
Intervention: Waitlist group (no treatment during the study period).
Number of subjects: 49
Study: 8500318

Group type: EXPERIMENTAL
Intervention: Topical ophthalmic medications (specific medications not detailed)
Number of subjects: 320

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 320
Study: 3436982

Group type: EXPERIMENTAL
Intervention: Passive exercise
Number of subjects: 6

Group type: COMPARATOR
Intervention: Static wrapping
Number of subjects: 6
Study: 31736328

Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Number of subjects: 4744

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4744
Study: 29277839

Group type: EXPERIMENTAL
Intervention: Synbiotic supplementation in SCFG (n = 22)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Synbiotic supplementation in SCFG with positive bacteriology (n = 10)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Placebo in PCFG (n = 19)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Control group (CG, n = 17)
Number of subjects: 78
Study: 27450419

Group type: EXPERIMENTAL
Intervention: Sulforaphane (SFN) supplementation with broccoli sprout homogenate
Number of subjects: 0
Study: 25703254

Group type: EXPERIMENTAL
Intervention: 1 mg estradiol plus 0.5 mg noretisterone acetate (NETA)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: 2 mg drospirenone (DRSP)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 23010419

Group type: EXPERIMENTAL
Intervention: High Calcium Diet (HCD; 1200-1300 mg/d)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Low Calcium Diet (LCD; <500 mg/d)
Number of subjects: 35
Study: 20172742

Group type: COMPARATOR
Intervention: Percutaneous endoscopic gastrostomy (PEG)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Percutaneous radiologic gastrostomy (PRG)
Number of subjects: 40
Study: 17134031

Group type: EXPERIMENTAL
Intervention: Intensive insulin therapy for 1 week
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control group (diet therapy or oral hypoglycemic agents)
Number of subjects: 16
Study: 14673602

Group type: EXPERIMENTAL
Intervention: Oleic acid-rich diet (high oleic acid sunflower oil)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Palmolein diet (rich in palmitic acid)
Number of subjects: 14
Study: 10996359

Group type: EXPERIMENTAL
Intervention: Insulin therapy
Number of subjects: 6
Study: 9310011

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin 250 mg
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin 500 mg
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin 1000 mg
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin 1500 mg
Number of subjects: 80

Group type: COMPARATOR
Intervention: Isoniazid 300 mg
Number of subjects: 80

Group type: COMPARATOR
Intervention: No drug
Number of subjects: 80
Study: 8443038

Group type: EXPERIMENTAL
Intervention: Ointment (radiolabelled with technetium‐99m tin colloid)
Number of subjects: 7

Group type: COMPARATOR
Intervention: 0.3% w/v HPMC solution (radiolabelled with technetium‐99m diethylenetriaminepentaacetic acid)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Ointment
Number of subjects: 7

Group type: COMPARATOR
Intervention: 0.3% w/v HPMC solution
Number of subjects: 7
Study: 3513594

Group type: EXPERIMENTAL
Intervention: levobunolol 0.5%
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: levobunolol 1%
Number of subjects: 92

Group type: COMPARATOR
Intervention: timolol 0.5%
Number of subjects: 92
Study: 31129911

Group type: EXPERIMENTAL
Intervention: Intravenous cangrelor
Number of subjects: 100

Group type: COMPARATOR
Intervention: Oral ticagrelor
Number of subjects: 100
Study: 28681435

Group type: EXPERIMENTAL
Intervention: Lenalidomide-based induction therapy
Number of subjects: 60

Group type: COMPARATOR
Intervention: Lenalidomide-naive controls
Number of subjects: 60
Study: 25741582

Group type: EXPERIMENTAL
Intervention: Triclosan toothpaste
Number of subjects: 383

Group type: COMPARATOR
Intervention: Placebo toothpaste
Number of subjects: 383
Study: 23802768

Group type: EXPERIMENTAL
Intervention: Vemurafenib treatment in BRAF(V600E/K) advanced melanoma
Number of subjects: 209
Study: 21453882

Group type: COMPARATOR
Intervention: 9mg budesonide once daily (OD)
Number of subjects: 343

Group type: EXPERIMENTAL
Intervention: 3g mesalazine granules OD
Number of subjects: 343
Study: 19324592

Group type: EXPERIMENTAL
Intervention: Ibuprofen
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study: 16319914

Group type: EXPERIMENTAL
Intervention: Nicotine nasal spray (1 mg)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo nasal spray
Number of subjects: 100
Study: 14967075

Group type: COMPARATOR
Intervention: Docetaxel alone (30 mg/m2 weekly for 6 weeks)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Trastuzumab alone (4 mg/kg intravenously on week 1 followed by 2 mg/kg per week thereafter)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Trastuzumab plus docetaxel combination therapy
Number of subjects: 13
Study: 10673248

Group type: EXPERIMENTAL
Intervention: Clopidogrel (75 mg) + Aspirin (100 mg)
Number of subjects: 700

Group type: COMPARATOR
Intervention: Ticlopidine (500 mg) + Aspirin (100 mg)
Number of subjects: 700
Study: 9084967

Group type: EXPERIMENTAL
Intervention: Topical glycopyrrolate
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study: 8518780

Group type: EXPERIMENTAL
Intervention: Nasal intermittent positive pressure ventilation (NIPPV)
Number of subjects: 0
Study: 3298410

Group type: EXPERIMENTAL
Intervention: alpha-2 recombinant interferon
Number of subjects: 0
Study: 31603979

Group type: EXPERIMENTAL
Intervention: Genetically increased telomere length (GI-TL)
Number of subjects: 337522
Study: 29310055

Group type: EXPERIMENTAL
Intervention: Mobilization with training (MTG)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Neuromuscular training (TG)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 45
Study: 27321384

Group type: EXPERIMENTAL
Intervention: Sugar-free chewing gum within the first 12 hours after surgery
Number of subjects: 41

Group type: COMPARATOR
Intervention: Usual therapy (control group)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Sugar-free chewing gum
Number of subjects: 41
Study: 25011991

Group type: EXPERIMENTAL
Intervention: Febuxostat
Number of subjects: 0

Group type: COMPARATOR
Intervention: Allopurinol
Number of subjects: 0
Study: 22388634

Group type: EXPERIMENTAL
Intervention: Boosted atazanavir (ATV/r)
Number of subjects: 201

Group type: COMPARATOR
Intervention: Ritonavir-boosted protease inhibitor (PI/r)
Number of subjects: 201
Study: 20052347

Group type: EXPERIMENTAL
Intervention: Weight Cycling (WC)
Number of subjects: 109

Group type: COMPARATOR
Intervention: Non-Weight Cycling (NWC)
Number of subjects: 109
Study: 18059580

Group type: EXPERIMENTAL
Intervention: OFTT with P/S ratio of 0.2
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: OFTT with P/S ratio of 2.0
Number of subjects: 8
Study: 16392537

Group type: EXPERIMENTAL
Intervention: Proprioceptive and balance exercise program
Number of subjects: 29

Group type: COMPARATOR
Intervention: Strengthening program
Number of subjects: 29
Study: 12019665

Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 20
Study: 10588620

Group type: EXPERIMENTAL
Intervention: Patient education intervention consisting of two 2‐h group sessions and 1 to 2 individual sessions by a trained nurse and physiotherapist, with a self‐management plan developed.
Number of subjects: 140

Group type: COMPARATOR
Intervention: Control group (uneducated patients).
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Patient education intervention for COPD patients.
Number of subjects: 140

Group type: COMPARATOR
Intervention: Control group (uneducated COPD patients).
Number of subjects: 140
Study: 10319301

Group type: EXPERIMENTAL
Intervention: Intralesional injection of triamcinolone
Number of subjects: 8